Welcome to our dedicated page for Nova SEC filings (Ticker: NVMI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking capital-intensive semiconductor suppliers like Nova Ltd (NVMI) means digging through hundreds of pages that detail R&D outlays, customer concentration and volatile chip-cycle demand. If you have ever searched “understanding Nova SEC documents with AI” or asked, “Where can I find Nova’s quarterly earnings report 10-Q filing?”, you know the challenge: the information is there, just hard to surface.
Stock Titan eliminates that hurdle. Our platform streams every Nova filing from EDGAR the moment it appears—10-K annual reports, 10-Q earnings updates, 8-K material events, even Nova Ltd insider trading Form 4 transactions. AI-powered summaries translate technical discussion of metrology revenue by process node into plain language, highlight executive stock transactions, and flag new risk factors in seconds. Need Nova’s proxy statement executive compensation tables? They’re extracted and linked, with context that shows how pay aligns with tool sales growth.
Use the data the way professionals do: compare capital-equipment backlog trends across quarters, receive alerts for Nova Ltd Form 4 insider transactions real-time, and drill into segment margins without scrolling through PDF footnotes. Whether you’re studying a Nova annual report 10-K simplified for strategic positioning or reviewing a sudden 8-K supplier disruption, our expert analysis and AI summaries put the key numbers front and center—saving hours and sharpening decisions.
Nova Ltd. (Nasdaq: NVMI) announced on
Form 144 for NVMI (NOVA LTD.) reports proposed and recent insider sales of ordinary shares. The notice states 1,360 ordinary shares are proposed for sale through Oppenheimer & Co. with an aggregate market value of $434,737.60 and an approximate sale date of 10/01/2025 on Nasdaq. The filer indicates those shares were acquired as restricted stock units on 06/23/2022 totaling 1,814 units and paid on that date. The filing also discloses sales by the named person during the past three months: 479 shares on 09/15/2025 for $143,221, 303 shares on 09/22/2025 for $96,960, and 549 shares on 10/01/2025 for $175,680. The form includes the standard seller representation about material nonpublic information and references Rule 10b5-1 language where applicable.
NOVA Ltd. (NVMI) Form 144 summary: An individual proposes to sell 852 ordinary shares through Oppenheimer & Co. on Nasdaq, with an aggregate market value of $263,770.68. The issuer shows 29,278,401 shares outstanding. The 852 shares were acquired as Restricted Stock Units (RSUs) on 05/18/2023 and were paid/issued on that date. The filer also reported multiple ordinary-share sales by the same person during the past three months: 135, 720, 1,390, and 479 shares on specified dates, with listed gross proceeds. The notice includes the standard attestation that the seller is not aware of undisclosed material adverse information.
NOVA Ltd. (NVMI) filing a Form 144 notifies the proposed sale of 426 ordinary shares on 09/15/2025 via Oppenheimer & Co. on Nasdaq, with an aggregate market value of $124,860.60. The filing shows 29,278,401 shares outstanding. The securities to be sold were acquired as restricted stock units on 05/18/2023 (1,704 units reported acquired). The notice also reports a prior sale within three months: Sagiv Sarit sold 1,281 ordinary shares on 09/11/2025 for gross proceeds of $358,744.05. The filer certifies there is no undisclosed material information and includes standard Rule 10b5-1/trading-plan language.
NOVA Ltd. (NVMI) filed a Form 144 reporting a proposed sale of 1,500 ordinary shares through Oppenheimer & Co. on Nasdaq with an aggregate market value of $439,650. The filing lists total outstanding shares of 29,278,401. The securities to be sold were acquired as restricted stock units on four dates in 2021–2023 totaling 1,910 shares (520, 514, 570, 306). The filer also disclosed a prior sale on 06/25/2025 of 2,051 shares for gross proceeds of $523,005. The notice includes the seller's representation that no undisclosed material adverse information is known.
Form 144 for NOVA LTD. (NVMI) reports a proposed sale of 479 ordinary shares through Oppenheimer & Co. on 09/15/2025 with an aggregate market value of $140,394.90. The filing shows 29,278,401 shares outstanding for the class. The shares to be sold were acquired as restricted stock units on 06/24/2021 (639 units). The filer also disclosed three recent transactions in the past three months by Simon Zehava: 135 shares on 06/24/2025 for $32,400, 720 shares on 06/26/2025 for $188,640, and 1,390 shares on 06/30/2025 for $391,980. The form includes the standard representation that the seller is not aware of undisclosed material information.
Form 144 notice for Nova Ltd. (NVMI): The filer reports a proposed sale of 1,281 ordinary shares through Oppenheimer & Co. Inc., listed on Nasdaq, with an aggregate market value of $356,310.15. The filing lists the total number of shares outstanding as 29,278,401 and gives an approximate sale date of 09/11/2025.
The securities to be sold were originally acquired as restricted stock units: 1,605 shares on 06/23/2022, 1,814 shares on 06/23/2022, and 1,704 shares on 05/18/2023. The filer reports no securities sold in the past three months for the account whose sale is proposed. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.
Form 144 notice for Nova Ltd. (NVMI) shows a proposed sale of 6,667 ordinary shares through Oppenheimer & Co. on 09/08/2025 with an aggregate market value of $1,704,751.90. The filing lists total shares outstanding as 29,278,401. The shares to be sold were acquired as restricted stock units (RSUs) on multiple dates: 09/01/2019 (8,500), 10/01/2020 (4,967), 09/01/2021 (5,000), 09/01/2022 (5,000), and 09/01/2023 (3,200). The filer reports "Nothing to Report" for securities sold during the past three months. The notice includes the standard representation that the seller is not aware of any undisclosed material adverse information about the issuer.
Form 144 notice for NVMI shows a proposed sale of 2,220 ordinary shares through Oppenheimer & Co. Inc., with an aggregate market value of 526,495.20 and an approximate sale date of 09/03/2025 on Nasdaq. The filing identifies the securities were acquired as Restricted Stock Units on 09/01/2021 (7,000), 09/01/2022 (4,875), 09/01/2023 (2,250) and 09/01/2024 (766). Total outstanding shares listed are 29,278,401. The filer certifies they are not aware of any undisclosed material adverse information and no sales in the past three months are reported.
FAQ
What is the current stock price of Nova (NVMI)?
What is the market cap of Nova (NVMI)?
